| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Allogeneic Stem Cell Transplantation for Multiple Myeloma: Maxi, Mini, or in Between
|
Bensinger, William
|
|
2009
|
9 |
S2 |
p. S54-S55
2 p.
|
article
|
| 2 |
Antiangiogenic Agents in Multiple Myeloma
|
Kumar, Shaji
|
|
2009
|
9 |
S2 |
p. S44-S45
2 p.
|
article
|
| 3 |
Canadian Collaborative Trials
|
Reece, Donna E.
|
|
2009
|
9 |
S2 |
p. S35-S36
2 p.
|
article
|
| 4 |
Curing Multiple Myeloma: Lessons from Total Therapy Protocols
|
Barlogie, Bart
|
|
2009
|
9 |
S2 |
p. S52-S54
3 p.
|
article
|
| 5 |
Current Status and Future Directions of Hematopoietic Stem Cell Transplantation in Myeloma: Moving Beyond High-Dose Melphalan
|
Qazilbash, Muzaffar H.
|
|
2009
|
9 |
S2 |
p. S48-S49
2 p.
|
article
|
| 6 |
Cytokine Pathways in Myeloma Growth and Survival
|
Sprynski, Anne Catherine
|
|
2009
|
9 |
S2 |
p. S16-S17
2 p.
|
article
|
| 7 |
Defining Multiple Myeloma as a Target for DNA Fusion Gene Vaccines
|
Sahota, Surinder S.
|
|
2009
|
9 |
S2 |
p. S23-S24
2 p.
|
article
|
| 8 |
Epigenetic Regulation of Multiple Myeloma Within its Bone Marrow Microenvironment
|
Vanderkerken, Karin
|
|
2009
|
9 |
S2 |
p. S29-S30
2 p.
|
article
|
| 9 |
Genes and Proteins of Myeloma Endothelial Cells to Search Specific Targets of the Tumor Vasculature
|
Vacca, Angelo
|
|
2009
|
9 |
S2 |
p. S28-S29
2 p.
|
article
|
| 10 |
Genetic Changes in Myeloma: Prognostic Implications
|
Avet-Loiseau, Hervé
|
|
2009
|
9 |
S2 |
p. S8-S9
2 p.
|
article
|
| 11 |
Growth and Survival Signals in Myeloma: Roles for BAFF and APRIL?
|
Jelinek, Diane F.
|
|
2009
|
9 |
S2 |
p. S19-S21
3 p.
|
article
|
| 12 |
High-Throughput Molecular Profiling: Insights into Myeloma Pathogenesis and Clinical Outcome
|
Morgan, Gareth
|
|
2009
|
9 |
S2 |
p. S10-
1 p.
|
article
|
| 13 |
Immune Microenvironment in Myeloma Pathobiology
|
Dhodapkar, Madhav V.
|
|
2009
|
9 |
S2 |
p. S21-S22
2 p.
|
article
|
| 14 |
Modulation of Signaling Cascades by Inhibitors of Histone Deacetylase and Akt
|
Hideshima, Teru
|
|
2009
|
9 |
S2 |
p. S12-S13
2 p.
|
article
|
| 15 |
Molecular Pathogenesis of MGUS and Multiple Myeloma
|
Kuehl, WM
|
|
2009
|
9 |
S2 |
p. S11-
1 p.
|
article
|
| 16 |
Molecular Pathways Induced by Tumor–Microenvironment Interactions in Myeloma and the Regulatory Role of Heat-Shock Proteins
|
Mitsiades, Constantine S.
|
|
2009
|
9 |
S2 |
p. S13-S14
2 p.
|
article
|
| 17 |
Monoclonal Antibody–Based Therapies in Human Multiple Myeloma
|
Tai, Yu-Tzu
|
|
2009
|
9 |
S2 |
p. S22-S23
2 p.
|
article
|
| 18 |
New Combination Approaches for Multiple Myeloma
|
Palumbo, Antonio
|
|
2009
|
9 |
S2 |
p. S42-S43
2 p.
|
article
|
| 19 |
New Insights into the Molecular Basis of Multiple Myeloma Pathogenesis and Prognosis
|
Shaughnessy Jr, John D.
|
|
2009
|
9 |
S2 |
p. S10-S11
2 p.
|
article
|
| 20 |
New Proteasome Inhibitors
|
Orlowsk, Robert Z.
|
|
2009
|
9 |
S2 |
p. S43-S44
2 p.
|
article
|
| 21 |
Novel Antigentic Targets for Immunotherapy in Myeloma
|
Yi, Qing
|
|
2009
|
9 |
S2 |
p. S18-S19
2 p.
|
article
|
| 22 |
Novel Anti-Myeloma Agents and Bone Metabolism: Implications in the Management of Myeloma Bone Disease
|
Terpos, Evangelos
|
|
2009
|
9 |
S2 |
p. S30-S32
3 p.
|
article
|
| 23 |
Novel Bone-Targeting Agents in Multiple Myeloma
|
Vallet, Sonia
|
|
2009
|
9 |
S2 |
p. S45-S46
2 p.
|
article
|
| 24 |
Novel Combination Therapies for the Treatment of Relapsed/Refractory Multiple Myeloma: Current Phase I/II Combinations
|
Richardson, Paul
|
|
2009
|
9 |
S2 |
p. S40-S42
3 p.
|
article
|
| 25 |
p62: A Potential Target for Blocking Microenvironmental Support of Myeloma
|
Roodman, G. David
|
|
2009
|
9 |
S2 |
p. S25-S26
2 p.
|
article
|
| 26 |
Phase III Studies Published by the IFM (Intergroupe Francophone du Myélome)
|
Moreau, Philip
|
|
2009
|
9 |
S2 |
p. S33-S34
2 p.
|
article
|
| 27 |
Phase III Trials for Multiple Myeloma in Northern Europe
|
Sonneveld, Pieter
|
|
2009
|
9 |
S2 |
p. S39-
1 p.
|
article
|
| 28 |
Pomalidomide (CC4047) plus Low-Dose Dexamethasone (Pom/Dex) as Therapy for Relapsed Multiple Myeloma
|
Lacy, Martha Q.
|
|
2009
|
9 |
S2 |
p. S46-S47
2 p.
|
article
|
| 29 |
Posttransplantation Maintenance in Patients with Multiple Myeloma
|
Facon, Thierry
|
|
2009
|
9 |
S2 |
p. S55-S56
2 p.
|
article
|
| 30 |
Redefining Risk Using Cytogenetic Changes
|
Drach, Johannes
|
|
2009
|
9 |
S2 |
p. S9-S10
2 p.
|
article
|
| 31 |
RNAi Vulnerability Map in Multiple Myeloma
|
Stewart, A. Keith
|
|
2009
|
9 |
S2 |
p. S14-
1 p.
|
article
|
| 32 |
Role of Fluorescence in Situ Hybridization in Myeloma Risk Stratification
|
Fonseca, Rafael
|
|
2009
|
9 |
S2 |
p. S6-S8
3 p.
|
article
|
| 33 |
Single or Double Autologous Stem Cell Transplantation Before and After the Era of Novel Agents
|
Cavo, Michele
|
|
2009
|
9 |
S2 |
p. S51-S52
2 p.
|
article
|
| 34 |
Statistical Issues in the Design and Analysis of Clinical Studies in Myeloma
|
Crowley, John
|
|
2009
|
9 |
S2 |
p. S39-
1 p.
|
article
|
| 35 |
Targeting NF-κB Signaling in Multiple Myeloma
|
Bergsagel, P. Leif
|
|
2009
|
9 |
S2 |
p. S14-S16
3 p.
|
article
|
| 36 |
The Activity of Spanish and Italian Myeloma Groups
|
Boccadoro, Mario
|
|
2009
|
9 |
S2 |
p. S36-S39
4 p.
|
article
|
| 37 |
Timing of Stem Cell Transplantation in the Era of Novel Agents
|
Weber, Donna M.
|
|
2009
|
9 |
S2 |
p. S49-S51
3 p.
|
article
|
| 38 |
Trafficking of Multiple Myeloma Cells: What Regulates Homing, Adhesion, and Mobilization of Multiple Myeloma to and from the Bone Marrow Niches
|
Ghobrial, Irene M.
|
|
2009
|
9 |
S2 |
p. S26-S27
2 p.
|
article
|
| 39 |
US Cooperative Group Trials
|
Lonial, Sagar
|
|
2009
|
9 |
S2 |
p. S34-S35
2 p.
|
article
|
Journal description